Peripheral neuropathy caused by proteolipid protein gene mutations

被引:32
作者
Garbern, JY
Cambi, F
Lewis, R
Shy, M
Sima, A
Kraft, G
Vallat, JM
Bosch, EP
Hodes, ME
Dlouhy, S
Raskind, W
Bird, T
Macklin, W
Kamholz, J
机构
[1] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA
[3] Thomas Jefferson Univ, Sch Med, Dept Neurol, Philadelphia, PA 19107 USA
[4] Univ Washington, Sch Med, Dept Phys Med & Rehabil, Seattle, WA 98195 USA
[5] Univ Hosp Limoges, Dept Neurol, F-87042 Limoges, France
[6] Mayo Clin Scottsdale, Neurol Sect, Scottsdale, AZ 85259 USA
[7] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[8] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA
[9] Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA
来源
CHARCOT-MARIE-TOOTH DISORDERS | 1999年 / 883卷
关键词
D O I
10.1111/j.1749-6632.1999.tb08597.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pelizaeus-Merzbacher disease (Ph LD) is a dysmyelinating disorder of the central nervous system typically caused by duplications or missense mutations of the proteolipid protein (PLP) gene, Most investigators have found that peripheral nerve function and structure is normal in PMD patients. We have found that null mutations of the PLP gene cause demyelinating peripheral neuropathy, whereas duplications and a proline 14 to leucine mutation do not affect nerve function. A family with a nonsense mutation at position 144, which affects only PLP but not the alternatively spliced gene product DM20, has a very mild syndrome, including normal peripheral nerve function. Our findings suggest that DM20 alone is sufficient to maintain normal nerve function and that there may be domains of PLP/DM20 that have a relatively more active role in the peripheral nervous system compared with that in the central nervous system.
引用
收藏
页码:351 / 365
页数:15
相关论文
共 53 条
[1]   PROTEOLIPID PROTEIN AND DM-20 ARE SYNTHESIZED BY SCHWANN-CELLS, PRESENT IN MYELIN MEMBRANE, BUT THEY ARE NOT FATTY ACYLATED [J].
AGRAWAL, HC ;
AGRAWAL, D .
NEUROCHEMICAL RESEARCH, 1991, 16 (08) :855-858
[2]   PROTEIN-KINASE-C ACTIVITY MODULATES MYELIN GENE-EXPRESSION IN ENRICHED OLIGODENDROCYTES [J].
ASOTRA, K ;
MACKLIN, WB .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 34 (05) :571-588
[3]  
BAER ROBERT D., 1965, ARCH PHYS MED REHABIL, V46, P698
[4]  
BIZZOZERO OA, 1986, J NEUROCHEM, V47, P772
[5]   DM20 MESSENGER-RNA SPLICE PRODUCT OF THE MYELIN PROTEOLIPID PROTEIN GENE IS EXPRESSED IN THE MURINE HEART [J].
CAMPAGNONI, CW ;
GARBAY, B ;
MICEVYCH, P ;
PRIBYL, T ;
KAMPF, K ;
HANDLEY, VW ;
CAMPAGNONI, AT .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 33 (01) :148-155
[6]  
Gamstorp I., 1963, ACTA PAEDIATR SC S, P68
[7]   Proteolipid protein is necessary in peripheral as well as central myelin [J].
Garbern, JY ;
Cambi, F ;
Tang, XM ;
Sima, AAF ;
Vallat, JM ;
Bosch, EP ;
Lewis, R ;
Shy, M ;
Sohi, J ;
Kraft, G ;
Chen, KL ;
Joshi, I ;
Leonard, DGB ;
Johnson, W ;
Raskind, W ;
Dlouhy, SR ;
Pratt, V ;
Hodes, ME ;
Bird, T ;
Kamholz, J .
NEURON, 1997, 19 (01) :205-218
[8]   Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease [J].
Gow, A ;
Southwood, CM ;
Lazzarini, RA .
JOURNAL OF CELL BIOLOGY, 1998, 140 (04) :925-934
[9]   MANY NATURALLY-OCCURRING MUTATIONS OF MYELIN PROTEOLIPID PROTEIN IMPAIR ITS INTRACELLULAR-TRANSPORT [J].
GOW, A ;
FRIEDRICH, VL ;
LAZZARINI, RA .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 37 (05) :574-583
[10]   A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease [J].
Gow, A ;
Lazzarini, RA .
NATURE GENETICS, 1996, 13 (04) :422-428